Capstone Investment Advisors
HRMY icon

Capstone Investment Advisors’s Harmony Biosciences HRMY Stock Holding History

Capstone Investment Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$814K Buy
29,061
+15,446
+113% +$506K ﹤0.01% 930
2025
Q4 		$509K Buy
13,615
+1,340
+11% +$44.1K ﹤0.01% 1142
2025
Q3 		$338K Buy
+12,275
New +$423K ﹤0.01% 1595

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Capstone Investment Advisors's HRMY Position: Q1 2026 in Review

Capstone Investment Advisors increased its Harmony Biosciences (HRMY) stake by 113% in Q1 2026, buying an estimated $506K and bringing the position to 29,061 shares worth $814K. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Capstone Investment Advisors first reported a position in HRMY in Q3 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Capstone Investment Advisors held 29,061 shares of Harmony Biosciences worth $814K as of Q1 2026.
  • Capstone Investment Advisors bought 15,446 Harmony Biosciences shares in Q1 2026, an estimated $506K.
  • Harmony Biosciences made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #930 holding.
  • Capstone Investment Advisors first reported a position in Harmony Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.